Related Experiment Video
Updated: Mar 18, 2026

Measuring Trans-Plasma Membrane Electron Transport by C2C12 Myotubes
Published on: May 4, 2018
Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one
Y Yamamoto1, T Kuwahara1, K Watanabe2
1a Research Center for Advanced Science and Technology , University of Tokyo , Tokyo , Japan.
Abstract:
The antioxidant activity of an anti-ischemic agent, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), was examined. The pKa value of MCI-186 is 7.0 and the rate of oxidation of MCI-186 initiated with an azo compound increased with increasing pH, suggesting that the anionic form of MCI-186 is much more reactive than the non-ionic form. The major products were 3-methyl-1-phenyl-2-pyrazolin-4,5-dione (4,5-dione) and 2-oxo-3-(phenylhydrazono)-butanoic acid (OPB). Hydrolysis of 4,5-dione gave OPB. The minor intermediate product was 4-hydroxy-4-(3-methyl-1-phenyl-1H-pyrazolin-5-on-4-yl)-3-methyl-1-phenyl-1H-pyrazolin-5-one (BPOH). The nucleophilic attack of the anionic form of MCI-186 to 4,5-dione is likely to give BPOH. MCI-186 (50 μM) inhibited the aerobic oxidation at 37°C of 5.2 mM unilamellar soybean phosphatidylcholine (PC) liposomal membranes, initiated with a water-soluble initiator, as efficientlyas did ascorbate (100 μM). MCI-186 (50 μM) also inhibited the oxidation of the same PC liposomal membranes, this time initiated with a lipid-soluble initiator, almost as efficiently as did α-tocopherol (2 μM). Furthermore, the combination of MCI-186 with ascorbate or α-tocopherol showed almost complete inhibition of PC oxidation induced by both initiators. These data suggest that MCI-186 may work as a good antioxidant in cellular systems as well as in cell-free systems.
Insights
The anti-ischemic agent 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186) demonstrates potent antioxidant activity. It effectively inhibits lipid peroxidation in liposomal membranes, suggesting its potential as an antioxidant in biological systems.
Area of Science:
- Biochemistry
- Medicinal Chemistry
Background:
- The anti-ischemic agent 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186) possesses antioxidant properties.
- Understanding its antioxidant mechanism is crucial for its therapeutic applications.
Purpose of the Study:
- To investigate the antioxidant activity and mechanism of MCI-186.
- To evaluate its efficacy in inhibiting lipid peroxidation in liposomal membranes.
Main Methods:
- Assessed the oxidation rate of MCI-186 at varying pH levels.
- Identified major and minor oxidation products.
- Examined the inhibition of phosphatidylcholine (PC) liposomal membrane oxidation using both water-soluble and lipid-soluble initiators.
- Evaluated the synergistic effects of MCI-186 with ascorbate and α-tocopherol.
Main Results:
- The anionic form of MCI-186, with a pKa of 7.0, exhibited higher reactivity.
- MCI-186 effectively inhibited PC liposomal membrane oxidation initiated by both water-soluble and lipid-soluble agents.
- Combination therapy with MCI-186 and other antioxidants (ascorbate, α-tocopherol) resulted in near-complete inhibition of oxidation.
Conclusions:
- MCI-186 functions as a potent antioxidant by inhibiting lipid peroxidation.
- Its efficacy in both cell-free and cellular systems suggests significant therapeutic potential.
Related Concept Videos
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
Radical Autoxidation
Electron Paramagnetic Resonance (EPR) Spectroscopy: Organic Radicals
Reactions at the Benzylic Position: Oxidation and Reduction
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Radical Reactivity: Steric Effects
Along with electronic...

